COMMUNIQUÉS West-GlobeNewswire

Sientra Reports Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
Remains on Track for Full and Final FDA Approval for U.S. Manufactured Implants Received ISO 13485 Certification for Breast Implants and Tissue Expanders Advanced miraDry Integration and Optimization Strategy SANTA [...]
How to Control Oily Skin - 10 Do’s and Don’ts from Dermatologists; American Academy of Dermatology
13/03/2018
ROSEMONT, Ill., March 13, 2018 (GLOBE NEWSWIRE) -- Although oily skin can clog pores and lead to increased acne breakouts, dermatologists from the American Academy of Dermatology say oily skin also has many benefits. [...]
Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing
13/03/2018
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced it has completed a Series [...]
Novozymes A/S’ annual shareholders’ meeting 2018
13/03/2018
Please read the full announcement in the attached PDF 2018_08_Novozymes_annual_shareholders_meeting_EN
CROSSJECT :Information relative au nombre de droits de vote et d'actions composant le capital social
13/03/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 13 mars 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
2017: a year of very significant reinforcement of the cash position (€274M at 12.31.2017), with all programs in the Company's pipeline moving forward
13/03/2018
2017: a year of very significant reinforcement of the cash position (€274M at 12.31.2017), with all programs in the Company's pipeline moving forward Financial results reflect in particular the signficiant ramp-up of [...]
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société
13/03/2018
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société Résultats financiers [...]
VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya
13/03/2018
Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Lyon (France), March 13, 2018 - Valneva SE, a fully integrated commercial stage biotech company focused on [...]
VALNEVA initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya
13/03/2018
Valneva initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya Lyon, France, 13 mars 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée [...]
Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference
13/03/2018
DUBLIN - March 13, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the Oppenheimer 28 th Annual Healthcare Conference on Tuesday, March 20, 2018, in New [...]
Medical Prognosis Institute publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger between Medical Prognosis Institute and Oncology Venture
13/03/2018
Hørsholm, Denmark - Medical Prognosis Institute A/S ("MPI") (Nasdaq First North Stockholm: MPI) today publishes selected financial information for the period 1 July 2017 - 31 December 2017 due to the proposed merger [...]
Shire Applies to Cease to be a Reporting Issuer in Canada
13/03/2018
Shire Applies to Cease to be a Reporting Issuer in Canada Dublin, Ireland - 13 March 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) ("Shire" or the "Company") announces that it has applied to the Autorité des marchés [...]
Immuron Progresses Discussions with Institutional Funds
13/03/2018
MELBOURNE, Australia, March 13, 2018 (GLOBE NEWSWIRE) -- Immuron Limited (ASX:IMC) (NASDAQ: IMRN ), an Australian microbiome biopharmaceutical company focused on developing and commercializing orally delivered targeted [...]
Gemphire Therapeutics to Announce Fourth Quarter and Year End 2017 Financial Results on Thursday, March 15
13/03/2018
LIVONIA, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]
TrustedHealth Launches Global Network for Treatment of Life-Threatening Diseases, Presenting at World Health Organization
13/03/2018
NEW YORK, March 13, 2018 (GLOBE NEWSWIRE) -- TrustedHealth , a blockchain-based patient and doctor-centric health ecosystem in specialized medicine, is launching to increase access to condition-specific specialists [...]
Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update
13/03/2018
Completes Sale of Hyperimmune Commercial Business for up to $74.5 Million Forms Strategic Bispecific Antibody Partnership with Alligator Bioscience Demonstrating Versatility of the ADAPTIR™ Technology Platform Advances [...]
NSS Labs Initiates Group Test Coverage of the Endpoint Detection and Response Market
13/03/2018
AUSTIN, Texas, March 13, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that it is expanding on its strong foundation of [...]
Predictive Technology Group Announces Presentations of Clinical Research Relating to the Role of Genetics in Endometriosis at the Society for Reproductive Investigation Meeting
13/03/2018
SALT LAKE CITY, March 13, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTCPINK:PRED), a life-sciences technology company, today announces new clinical data relating to the role of genetics in the [...]
Exalenz Bioscience’s BreathID® Hp & BreathID Hp Lab Systems Receive FDA Clearance for Diagnosis of Helicobacter pylori Testing in Pediatric Patients
13/03/2018
MODI'IN, Israel and MANASQUAN, N.J., March 13, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE: EXEN ), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of [...]

Pages